AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma

PURPOSE: Esophageal squamous cell carcinoma (ESCC) is a refractory malignancy with high morbidity and mortality. Thus, there is an urgent need to find effective targets and agents for ESCC treatment. The purpose of this study was to assess the anti-ESCC effects of a pan-histone deacetylase (HDAC) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuxuan, Yuan, Ting, Zhang, Yuan, Shi, Jianyou, Bai, Lan, Duan, Xingmei, Tong, Rongsheng, Zhong, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930838/
https://www.ncbi.nlm.nih.gov/pubmed/31908417
http://dx.doi.org/10.2147/DDDT.S211665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930838/
https://www.ncbi.nlm.nih.gov/pubmed/31908417
http://dx.doi.org/10.2147/DDDT.S211665

Ejemplares similares